Phase II study of carboplatin in recurrent ovarian cancer: severe hematologic toxicity in previously treated patients - Concepedia

Concepedia

Publication | Closed Access

Phase II study of carboplatin in recurrent ovarian cancer: severe hematologic toxicity in previously treated patients

18

Citations

8

References

1989

Year

Nicoletta Colombo, James L. Speyer, Michael R. Green, Renzo Canetta, Uziel Beller, James C. Wernz, Marleen Meyers, Tova Widman, Ronald H. Blum, Martine Piccart,

Cancer Chemotherapy and Pharmacology

MedicineMetronomic TherapySevere Hematologic ToxicityGynecologyRecurrent Ovarian CancerPhase Ii StudyCancer TreatmentOncologyRadiation OncologyOvarian Cancer

References

	Year	Citations

Page 1

Page 1